Autoimmune Diseases  >>  Benlysta (belimumab)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Benlysta (belimumab) / GSK
BLISS-52, NCT00424476: A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)

Checkmark Pooled analysis: BLISS 52 and BLISS 76, EULAR 2013
May 2013 - May 2013: Pooled analysis: BLISS 52 and BLISS 76, EULAR 2013
Checkmark BLISS-52; BLISS-76
Mar 2013 - Mar 2013: BLISS-52; BLISS-76
Checkmark Lupus 2013
More
Completed
3
865
Europe, RoW
Placebo, Belimumab 1 mg/kg, BENLYSTA™ (formerly LymphoStat-B™), Belimumab 10 mg/kg
Human Genome Sciences Inc., GlaxoSmithKline
Systemic Lupus Erythematosus
05/09
03/10
BLISS-76, NCT00410384 / 2006-005177-21: A Study of Belimumab in Subjects With Systemic Lupus Erythematosus

Checkmark Systemic Lupus Erythematosus - ACR/ARHP (BLISS-76)
Sep 2013 - Sep 2013: Systemic Lupus Erythematosus - ACR/ARHP (BLISS-76)
Checkmark Pooled analysis: BLISS 52 and BLISS 76, EULAR 2013
May 2013 - May 2013: Pooled analysis: BLISS 52 and BLISS 76, EULAR 2013
Checkmark BLISS-52; BLISS-76
More
Completed
3
819
US, Canada, Europe, RoW
Placebo, Belimumab 1 mg/kg, LymphoStat-B™, belimumab, Belimumab 10 mg/kg
Human Genome Sciences Inc., GlaxoSmithKline
Systemic Lupus Erythematosus
09/09
03/10
BLISS-SC, NCT01484496 / 2011-003814-18: A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)

Checkmark BLISS-SC
Nov 2017 - Nov 2017: BLISS-SC
Checkmark From BLISS S/C trial for systemic lupus erythematosus
Jun 2016 - Jun 2016: From BLISS S/C trial for systemic lupus erythematosus
Checkmark BLISS-SC trial in SLE at ACR 2015
More
Completed
3
839
Japan, US, Europe, RoW
Placebo, Belimumab 200 mg SC, BENLYSTA™, Standard therapy
Human Genome Sciences Inc., a GSK Company, GlaxoSmithKline
Systemic Lupus Erythematosus
02/15
10/15
NCT00724867: A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States

Checkmark Systemic Lupus Erythematosus - ACR/ARHP (BLISS-76)
Sep 2013 - Sep 2013: Systemic Lupus Erythematosus - ACR/ARHP (BLISS-76)
Completed
3
268
US
Belimumab 1 mg/kg, BENLYSTA, HGS1006, LymphoStat-B™, Belimumab 10 mg/kg
Human Genome Sciences Inc., a GSK Company, GlaxoSmithKline
Systemic Lupus Erythematosus
03/15
03/15
BREVAS, NCT01663623: Belimumab in Remission of VASculitis

Checkmark P3 study initiation (Vasculitis)
Apr 2012 - Aug 2012: P3 study initiation (Vasculitis)
Completed
3
106
US, Canada, Europe, RoW
Placebo, Belimumab 10 mg/kg, BENLYSTA™, Azathioprine
Human Genome Sciences Inc., a GSK Company, GlaxoSmithKline
Vasculitis
02/17
02/17

Download Options